Advanced search
Publication Cover
Emerging Microbes & Infections Volume 8, 2019 - Issue 1
Submit an article Journal homepage
1,873
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus

Ya-Li Zhanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b School of Life Science, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Ying Gaoa State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;d Hainan Health Disseminate Centre, Haikou, People’s Republic of ChinaView further author information
,
Jia-Li Caoa State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b School of Life Science, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Jing-Hua Zhaob School of Life Science, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, People’s Republic of China;e Natural Medicine Institute of Zhejiang Yangshengtang, Hangzhou, People’s Republic of ChinaView further author information
,
Tian-Ying Zhanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b School of Life Science, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Chuan-Lai Yanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b School of Life Science, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Hua-Long Xionga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b School of Life Science, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Ying-Bin Wanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b School of Life Science, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Shan-Hai Ouc Xiamen Blood Service, Xiamen, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Tong Chenga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b School of Life Science, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-1638-6214View further author information
ORCID Icon,
Chang-Rong Chenf Xiamen Haicang Hospital, Xiamen, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Quan Yuana State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b School of Life Science, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5487-561XView further author information
ORCID Icon &
Ning-Shao Xiaa State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b School of Life Science, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-0179-5266View further author information
ORCID Icon show all
Pages 724-733 | Received 10 Feb 2019, Accepted 12 May 2019, Published online: 25 May 2019

References

  • Polaris Observatory C. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastro Hepat. 2018 Jun;3(6):383–403. PubMed PMID: 29599078. doi: 10.1016/S2468-1253(18)30056-6
  • Mortality GBD. Causes of Death C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jan 10;385(9963):117–171. PubMed PMID: 25530442; PubMed Central PMCID: PMC4340604. doi: 10.1016/S0140-6736(14)61682-2
  • Nayagam S, Thursz M, Sicuri E, et al. Requirements for global elimination of hepatitis B: a modelling study. Lancet Infect Dis. 2016 Dec;16(12):1399–1408. PubMed PMID: 27638356. doi: 10.1016/S1473-3099(16)30204-3
  • Chen DS. Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol. 2009 Apr;50(4):805–816. PubMed PMID: 19231008. doi: 10.1016/j.jhep.2009.01.002
  • Tajiri K, Ozawa T, Jin A, et al. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine. Antivir Res. 2010 Jul;87(1):40–49. PubMed PMID: 20412816. doi: 10.1016/j.antiviral.2010.04.006
  • Salisse J, Sureau C. A function essential to viral entry underlies the hepatitis B virus “a” determinant. J Virol. 2009 Sep;83(18):9321–9328. PubMed PMID: 19570861; PubMed Central PMCID: PMC2738268. doi: 10.1128/JVI.00678-09
  • Sureau C, Salisse J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology. 2013 Mar;57(3):985–994. PubMed PMID: 23161433. doi: 10.1002/hep.26125
  • Gao Y, Zhang TY, Yuan Q, et al. Antibody-mediated immunotherapy against chronic hepatitis B virus infection. Human Vaccine Immuno. 2017 Aug 3;13(8):1768–1773. PubMed PMID: 28521640; PubMed Central PMCID: PMC5557221. doi: 10.1080/21645515.2017.1319021
  • Zhang TY, Yuan Q, Zhao JH, et al. Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen. Gut. 2016 Apr;65(4):658–671. PubMed PMID: 26423112. doi: 10.1136/gutjnl-2014-308964
  • Schillie SF, Murphy TV. Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review. Vaccine. 2013 May 17;31(21):2506–2516. PubMed PMID: 23257713. doi: 10.1016/j.vaccine.2012.12.012
  • Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. New Engl J Med. 1980 Oct 9;303(15):833–841. PubMed PMID: 6997738. doi: 10.1056/NEJM198010093031501
  • Li J, Zong L, Sureau C, et al. Unusual features of sodium taurocholate cotransporting polypeptide as a hepatitis B virus receptor. J Virol. 2016 Sep 15;90(18):8302–8313. PubMed PMID: 27384660; PubMed Central PMCID: PMC5008102. doi: 10.1128/JVI.01153-16
  • Ladner SK, Otto MJ, Barker CS, et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Ch. 1997 Aug;41(8):1715–1720. PubMed PMID: 9257747; PubMed Central PMCID: PMC163991. doi: 10.1128/AAC.41.8.1715
  • Li A, Yuan Q, Huang Z, et al. Novel double-antigen sandwich immunoassay for human hepatitis B core antibody. Clin Vaccine Immunol. 2010 Mar;17(3):464–469. PubMed PMID: 20107008; PubMed Central PMCID: PMC2837963. doi: 10.1128/CVI.00457-09
  • Yuan Q, Song LW, Liu CJ, et al. Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients. Gut. 2013 Jan;62(1):182.2–18184. PubMed PMID: 22698651. doi: 10.1136/gutjnl-2012-302656
  • Ni Y, Lempp FA, Mehrle S, et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroentero. 2014 Apr;146(4):1070–1083.e6. PubMed PMID: 24361467. doi: 10.1053/j.gastro.2013.12.024
  • Marasco WA, Sui J. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat Biotechnol. 2007 Dec;25(12):1421–1434. PubMed PMID: 18066039. doi: 10.1038/nbt1363
  • Verrier ER, Colpitts CC, Schuster C, et al. Cell culture models for the investigation of hepatitis B and D virus infection. Viruses. 2016 Sep 20;8(9):261. PubMed PMID: 27657111; PubMed Central PMCID: PMCPMC5035974. doi: 10.3390/v8090261
  • Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife. 2012 Nov 13;1:e00049. PubMed PMID: 23150796; PubMed Central PMCID: PMC3485615. doi: 10.7554/eLife.00049
  • Sun Y, Qi Y, Peng B, et al. NTCP-Reconstituted in vitro HBV infection system. Methods Mol Biol. 2017;1540:1–14. PubMed PMID: 27975303. doi:10.1007/978-1-4939-6700-1_1.
  • Ni Y, Urban S. Hepatitis B virus infection of HepaRG cells, HepaRG-hNTCP cells, and primary human hepatocytes. Methods Mol Biol. 2017;1540:15–25. PubMed PMID: 27975304. doi:10.1007/978-1-4939-6700-1_2.
  • Yang HC, Tsou HH, Pei SN, et al. Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection. J Hepatol. 2018 Aug;69(2):286–292. PubMed PMID: 29551710. doi: 10.1016/j.jhep.2018.02.033

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.